CSIMarket


Yew Bio pharm Group Inc   (YEWB)
Other Ticker:  
 


 

Yew Bio pharm Group Inc

YEWB's Financial Statements and Analysis



Yew Bio pharm Group Inc reported in the third quarter of 2021 net loss per share of $-0.03 compare to earnings per share of $0.02 in the same quarter a year ago a decrease compare to $-0.01 realized in previous quarter.


third quarter of 2021
Earnings Per Share Revenues
$ -0.03 $  0 Mill
$-0.05     $-10M     -98.94 %



Yew Bio Pharm Group Inc 's Revenue fell by -98.94 % in third quarter of 2021 (Sep 30 2021) year on year, to $0 million and declined by -99.26 % sequentially.


Yew Bio Pharm Group Inc is

More on YEWB's Income Statement



Yew Bio Pharm Group Inc 's in thethird quarter of 2021 recorded net loss of $-1.559 million, compare to net income of $0.996 million achieved in III. Quarter a year ago.

Sequentially net loss advanced

More on YEWB's Growth

Yew Bio Pharm Group Inc Inventories
Inventories declined by -95.31 % to $0.12 million from III. Quarter a year ago, sequentially inventories rose by 11.59 %. In Sep 30 2021 company's net cash and cash equivalents decreased by $0 million, capital expenditures fell by -0.11318224.04%, to $0 millions compare to same quarter a year ago

More on YEWB's Cash flow Statement


Yew Bio pharm Group Inc does not pay out common stock dividend.

In trailing twelve-month period Yew Bio pharm Group Inc earned $ 0.23 cash per share, on a free-cash flow basis 2332.75 % of net earning per share.

Book value fell by -3.15 % sequentially to $0.91 per share.
Tangible Book value fell to $ 0.91 per share from $ 0.93.

Company repurchased 0.00 million shares or 0.00 % in Sep 30 2021.
Interest Coverage Ratio was 1.75. Debt Coverage Ratio was 0.1.

More on YEWB's Dividends

 Market Capitalization (Millions) 2
 Shares Outstanding (Millions) 52
 Total Debt (Millions $) 9
 Revenue (TTM) (Millions $) 29
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 86




Yew Bio pharm Group Inc does not pay out common stock dividend.

In trailing twelve-month period Yew Bio pharm Group Inc had $ 0.23 cash flow per share, on a free-cash flow basis 2332.75 % of net earning per share.

Book value fell by -3.15 % sequentially to $0.91 per share.
Tangible Book value fell to $ 0.91 per share from $ 0.93.

Company repurchased 0.00 million shares or 0.00 % in Sep 30 2021.
Interest Coverage Ratio was 1.75. Debt Coverage Ratio was 0.1.

More on YEWB's Balance Sheets

 Market Capitalization (Millions) 2
 Shares Outstanding (Millions) 52
 Total Debt (Millions $) 9
 Revenue (TTM) (Millions $) 29
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 86
   



Date modified: -0001-11-30T00:00:00+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com